Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
Study included a 24 week extension that did not occur due to FDA approval of the product.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Symptoms of OAB (urgency, with or without urge incontinence, usually with frequency and nocturia) for ≥3 or more months.
Patients may be included if they are on another OAB medication; however, patients must washout from other OAB medications for at least 7 days prior to receiving solifenacin succinate. Previous non-drug treatment of OAB is allowed if it has been established at least 4 weeks prior to study entry and is continued throughout the study.
You may not be if
-Significant stress incontinence or mixed stress/urge incontinence where stress is the predominant factor
Evidence of urinary tract infection; chronic inflammation such as interstitial cystitis and bladder stones
